Literature DB >> 15617596

Implanted ventricular shunts in the United States: the billion-dollar-a-year cost of hydrocephalus treatment.

Ravish V Patwardhan1, Anil Nanda.   

Abstract

OBJECTIVE: To characterize admissions related to ventricular shunts in the year 2000 in terms of diagnoses, procedures, socioeconomic status, and other related data.
METHODS: The Nationwide Inpatient Sample database (year 2000) was analyzed retrospectively. We reviewed 7.45 million patient admissions for primary International Classification of Diseases, 9th Revision, procedure codes 023 to 0243 (ventricular shunts to peritoneal, atrial, pleural, and urinary systems for initial placement, revision, and removal); admissions listing ventriculostomy placement (code 022) were excluded from analysis.
RESULTS: Five thousand five hundred seventy-four admissions were identified. Admission sources primarily were routine (58.8%) and the emergency department (32.4%). Admission types primarily were elective (43.3%), emergent (33.2%), and urgent (21.9%). The top three primary diagnoses treated were shunt malfunction (40.7%), noncommunicating hydrocephalus (16.6%), and communicating hydrocephalus (13.2%). Shunt infection was the primary diagnosis in 7.2% of admissions. Age frequency of admissions was nonparametric, being highest for infants; the average stay was 8.4 +/- 0.2 days (standard error range, 0-243 d). The most common procedures were ventriculoperitoneal shunt placement (43.4%) and ventricular shunt replacement (42.8%); ventricular shunt removal occurred in 7.3% of admissions, whereas ventricle-to-thorax (0.6%), ventricle-to-circulatory system (0.5%), and ventricle-to-urinary system (0.05%) shunts were rare. Average cost was $35,816 +/- $810 (standard error range, $137-$814,748). Primary payers primarily were private insurers (43.8%), Medicare (26.0%), and Medicaid (24.5%). Disposition mainly was routine (78.4%, with home health care in 6.5%), and inpatient mortality was 2.7%. There was no socioeconomic disproportion in treatment with respect to average household income.
CONCLUSION: Ventricular shunts as primary procedures constitute a significant medical and economic problem.

Entities:  

Mesh:

Year:  2005        PMID: 15617596     DOI: 10.1227/01.neu.0000146206.40375.41

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  56 in total

1.  Prophylactic antibiotics in pediatric shunt surgery.

Authors:  N Biyani; G Grisaru-Soen; P Steinbok; S Sgouros; S Constantini
Journal:  Childs Nerv Syst       Date:  2006-05-18       Impact factor: 1.475

2.  Laparoscopic versus open approach for implantation of the peritoneal catheter during ventriculoperitoneal shunt placement.

Authors:  Joshua L Argo; Durgamani K Yellumahanthi; Naveen Ballem; Mark R Harrigan; Winfield S Fisher; Mary M Wesley; Tracy H Taylor; Ronald H Clements
Journal:  Surg Endosc       Date:  2008-12-13       Impact factor: 4.584

Review 3.  Who will care for me next? Transitioning to adulthood with hydrocephalus.

Authors:  Tamara D Simon; Sara Lamb; Nancy A Murphy; Bonnie Hom; Marion L Walker; Edward B Clark
Journal:  Pediatrics       Date:  2009-10-19       Impact factor: 7.124

4.  Outcome of ventriculoperitoneal shunt and predictors of shunt revision in infants with posthemorrhagic hydrocephalus.

Authors:  Shyamal C Bir; Subhas Konar; Tanmoy Kumar Maiti; Piyush Kalakoti; Papireddy Bollam; Anil Nanda
Journal:  Childs Nerv Syst       Date:  2016-06-09       Impact factor: 1.475

Review 5.  Laparoscopy-assisted ventriculoperitoneal shunt surgery: personal experience and review of the literature.

Authors:  Soheila Raysi Dehcordi; Claudio De Tommasi; Alessandro Ricci; Sara Marzi; Cristina Ruscitti; Gianfranco Amicucci; Renato J Galzio
Journal:  Neurosurg Rev       Date:  2011-02-23       Impact factor: 3.042

Review 6.  Evidence-based interventions to reduce shunt infections: a systematic review.

Authors:  Nehaw Sarmey; Varun R Kshettry; Michael F Shriver; Ghaith Habboub; Andre G Machado; Robert J Weil
Journal:  Childs Nerv Syst       Date:  2015-02-17       Impact factor: 1.475

7.  Transverse sinus stenting for pseudotumor cerebri: a cost comparison with CSF shunting.

Authors:  R M Ahmed; F Zmudzki; G D Parker; B K Owler; G M Halmagyi
Journal:  AJNR Am J Neuroradiol       Date:  2013-11-28       Impact factor: 3.825

8.  On the changing epidemiology of hydrocephalus.

Authors:  Luca Massimi; Giovanna Paternoster; Teresa Fasano; Concezio Di Rocco
Journal:  Childs Nerv Syst       Date:  2009-02-24       Impact factor: 1.475

Review 9.  Hearing loss in hydrocephalus: a review, with focus on mechanisms.

Authors:  David Satzer; Daniel J Guillaume
Journal:  Neurosurg Rev       Date:  2015-08-18       Impact factor: 3.042

10.  Surgical management of craniosynostosis in the setting of a ventricular shunt: a case series and treatment algorithm.

Authors:  Michael S Golinko; Danielle N Atwood; Eylem Ocal
Journal:  Childs Nerv Syst       Date:  2017-11-06       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.